---
document_datetime: 2025-12-02 06:59:46
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/zevalin.html
document_name: zevalin.html
version: success
processing_time: 0.1075672
conversion_datetime: 2025-12-28 09:32:56.754626
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Zevalin

[RSS](/en/individual-human-medicine.xml/65653)

##### Lapsed

This medicine's authorisation has lapsed

ibritumomab tiuxetan Medicine Human Lapsed

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 4 January 2024 the marketing authorisation of Zevalin (Ibritumomab tiuxetan) ceased to be valid in the European Union (EU). The cessation of validity is due to the fact that the marketing authorisation holder, Ceft Biopharma s.r.o., discontinued marketing of Zevalin in the European Union (EU) in May 2020. In accordance with provisions of the sunset clause, the marketing authorisation of a medicinal product lapses if the product had not been marketed in any EU Member States for three consecutive years. The European Commission rejected a request for an exemption from the 'sunset clause' for Zevalin. Ceft Biopharma s.r.o. confirmed that it discontinued the marketing of the product due to manufacturing reasons.

Zevalin was granted marketing authorisation in the EU on 16 January 2004 for the treatment of nonHodgkin's lymphoma (NHL) and follicular lymphoma. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2009.

The European Public Assessment Report (EPAR) for Zevalin is updated to indicate that the marketing authorisation is no longer valid.

Zevalin : EPAR - Summary for the public

English (EN) (101.11 KB - PDF)

**First published:** 02/03/2009

**Last updated:** 27/09/2011

[View](/en/documents/overview/zevalin-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-518)

български (BG) (235.65 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/bg/documents/overview/zevalin-epar-summary-public_bg.pdf)

español (ES) (167.8 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/es/documents/overview/zevalin-epar-summary-public_es.pdf)

čeština (CS) (158.35 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/cs/documents/overview/zevalin-epar-summary-public_cs.pdf)

dansk (DA) (167.38 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/da/documents/overview/zevalin-epar-summary-public_da.pdf)

Deutsch (DE) (170.86 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/de/documents/overview/zevalin-epar-summary-public_de.pdf)

eesti keel (ET) (165.08 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/et/documents/overview/zevalin-epar-summary-public_et.pdf)

ελληνικά (EL) (316.18 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/el/documents/overview/zevalin-epar-summary-public_el.pdf)

français (FR) (124.1 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/fr/documents/overview/zevalin-epar-summary-public_fr.pdf)

italiano (IT) (171.86 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/it/documents/overview/zevalin-epar-summary-public_it.pdf)

latviešu valoda (LV) (235.47 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/lv/documents/overview/zevalin-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (207.27 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/lt/documents/overview/zevalin-epar-summary-public_lt.pdf)

magyar (HU) (131.89 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/hu/documents/overview/zevalin-epar-summary-public_hu.pdf)

Malti (MT) (152.17 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/mt/documents/overview/zevalin-epar-summary-public_mt.pdf)

Nederlands (NL) (104.93 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/nl/documents/overview/zevalin-epar-summary-public_nl.pdf)

polski (PL) (217.85 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/pl/documents/overview/zevalin-epar-summary-public_pl.pdf)

português (PT) (103.05 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/pt/documents/overview/zevalin-epar-summary-public_pt.pdf)

română (RO) (149.34 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/ro/documents/overview/zevalin-epar-summary-public_ro.pdf)

slovenčina (SK) (202.36 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/sk/documents/overview/zevalin-epar-summary-public_sk.pdf)

slovenščina (SL) (197.3 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/sl/documents/overview/zevalin-epar-summary-public_sl.pdf)

Suomi (FI) (170.1 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/fi/documents/overview/zevalin-epar-summary-public_fi.pdf)

svenska (SV) (102.28 KB - PDF)

**First published:**

02/03/2009

**Last updated:**

27/09/2011

[View](/sv/documents/overview/zevalin-epar-summary-public_sv.pdf)

Zevalin : EPAR - Risk-management-plan summary

English (EN) (223.87 KB - PDF)

**First published:** 29/06/2021

[View](/en/documents/rmp-summary/zevalin-epar-risk-management-plan-summary_en.pdf)

## Product information

Zevalin : EPAR - Product Information

English (EN) (993.89 KB - PDF)

**First published:** 03/11/2009

**Last updated:** 09/03/2020

[View](/en/documents/product-information/zevalin-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-49)

български (BG) (1.16 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/bg/documents/product-information/zevalin-epar-product-information_bg.pdf)

español (ES) (1.22 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/es/documents/product-information/zevalin-epar-product-information_es.pdf)

čeština (CS) (1.08 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/cs/documents/product-information/zevalin-epar-product-information_cs.pdf)

dansk (DA) (1.05 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/da/documents/product-information/zevalin-epar-product-information_da.pdf)

Deutsch (DE) (1.04 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/de/documents/product-information/zevalin-epar-product-information_de.pdf)

eesti keel (ET) (1.07 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/et/documents/product-information/zevalin-epar-product-information_et.pdf)

ελληνικά (EL) (1.35 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/el/documents/product-information/zevalin-epar-product-information_el.pdf)

français (FR) (1.19 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/fr/documents/product-information/zevalin-epar-product-information_fr.pdf)

hrvatski (HR) (1.15 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/hr/documents/product-information/zevalin-epar-product-information_hr.pdf)

íslenska (IS) (1.15 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/is/documents/product-information/zevalin-epar-product-information_is.pdf)

italiano (IT) (1.14 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/it/documents/product-information/zevalin-epar-product-information_it.pdf)

latviešu valoda (LV) (1.15 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/lv/documents/product-information/zevalin-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.09 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/lt/documents/product-information/zevalin-epar-product-information_lt.pdf)

magyar (HU) (1.15 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/hu/documents/product-information/zevalin-epar-product-information_hu.pdf)

Malti (MT) (1.3 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/mt/documents/product-information/zevalin-epar-product-information_mt.pdf)

Nederlands (NL) (1 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/nl/documents/product-information/zevalin-epar-product-information_nl.pdf)

norsk (NO) (1.01 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/no/documents/product-information/zevalin-epar-product-information_no.pdf)

polski (PL) (1.16 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/pl/documents/product-information/zevalin-epar-product-information_pl.pdf)

português (PT) (1006 KB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/pt/documents/product-information/zevalin-epar-product-information_pt.pdf)

română (RO) (1.28 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/ro/documents/product-information/zevalin-epar-product-information_ro.pdf)

slovenčina (SK) (1.08 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/sk/documents/product-information/zevalin-epar-product-information_sk.pdf)

slovenščina (SL) (1.1 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/sl/documents/product-information/zevalin-epar-product-information_sl.pdf)

Suomi (FI) (1.03 MB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/fi/documents/product-information/zevalin-epar-product-information_fi.pdf)

svenska (SV) (980.3 KB - PDF)

**First published:**

03/11/2009

**Last updated:**

09/03/2020

[View](/sv/documents/product-information/zevalin-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** II/0053 10/06/2021

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Zevalin : EPAR - All Authorised presentations

English (EN) (89.7 KB - PDF)

**First published:** 13/11/2006

**Last updated:** 13/11/2006

[View](/en/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-116)

български (BG) (113.57 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/bg/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_bg.pdf)

español (ES) (88.92 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/es/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_es.pdf)

čeština (CS) (113.13 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/cs/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (89.63 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/da/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (95.28 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/de/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (86.95 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/et/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (115.31 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/el/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_el.pdf)

français (FR) (88.95 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/fr/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (86.79 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/it/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (111.44 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/lv/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (108.71 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/lt/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (100.3 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/hu/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (109.14 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/mt/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (87.37 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/nl/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_nl.pdf)

polski (PL) (115.49 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/pl/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_pl.pdf)

português (PT) (90.8 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/pt/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_pt.pdf)

română (RO) (104.73 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/ro/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (112.29 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/sk/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (97.31 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/sl/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (85.11 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/fi/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (88.69 KB - PDF)

**First published:**

13/11/2006

**Last updated:**

13/11/2006

[View](/sv/documents/all-authorised-presentations/zevalin-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Zevalin Active substance ibritumomab tiuxetan International non-proprietary name (INN) or common name ibritumomab tiuxetan Therapeutic area (MeSH) Lymphoma, Follicular Anatomical therapeutic chemical (ATC) code V10XX02

### Pharmacotherapeutic group

Therapeutic radiopharmaceuticals

### Therapeutic indication

Zevalin is indicated in adults.

[ 90 Y]-radiolabelled Zevalin is indicated as consolidation therapy after remission induction in previously untreated patients with follicular lymphoma. The benefit of Zevalin following rituximab in combination with chemotherapy has not been established.

[ 90 Y]-radiolabelled Zevalin is indicated for the treatment of adult patients with rituximab relapsed

## Authorisation details

EMA product number EMEA/H/C/000547 Marketing authorisation holder

Ceft Biopharma s.r.o.

Trtinova 260/1 Cakovice, 196 00 Praha 9 Czech Republic

Opinion adopted 25/09/2003 Marketing authorisation issued 16/01/2004 Lapse of marketing authorisation 04/01/2024 Revision 23

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Zevalin : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (462.2 KB - PDF)

**First published:** 03/11/2009

**Last updated:** 29/06/2021

[View](/en/documents/procedural-steps-after/zevalin-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

Zevalin-H-C-PSUSA-1704-201704 - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Reference Number: EMA/821222/2017

English (EN) (118.12 KB - PDF)

**First published:** 12/12/2017

**Last updated:** 12/12/2017

[View](/en/documents/scientific-conclusion/zevalin-h-c-psusa-1704-201704-scientific-conclusions-grounds-recommending-variation-terms-marketing-authorisation_en.pdf)

Zevalin-H-C-547-II-18 : EPAR - Assessment Report - Variation

English (EN) (429.06 KB - PDF)

**First published:** 07/07/2008

**Last updated:** 07/07/2008

[View](/en/documents/variation-report/zevalin-h-c-547-ii-18-epar-assessment-report-variation_en.pdf)

CHMP post authorisation summary of positive opinion for  Zevalin on 19 March 2008

Adopted

Reference Number: EMEA/CHMP/144112/2008

English (EN) (57.79 KB - PDF)

**First published:** 30/03/2008

**Last updated:** 30/03/2008

[View](/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-zevalin-19-march-2008_en.pdf)

## Initial marketing authorisation documents

Zevalin : EPAR - Scientific Discussion

English (EN) (1.16 MB - PDF)

**First published:** 13/11/2006

**Last updated:** 13/11/2006

[View](/en/documents/scientific-discussion/zevalin-epar-scientific-discussion_en.pdf)

Zevalin : EPAR - Procedural steps taken before authorisation

English (EN) (122.53 KB - PDF)

**First published:** 13/11/2006

**Last updated:** 13/11/2006

[View](/en/documents/procedural-steps/zevalin-epar-procedural-steps-taken-authorisation_en.pdf)

**This page was last updated on** 10/07/2024

## Share this page

[Back to top](#main-content)